Bio < Article List - KBR

Bluemtec emerges as Medistaff's second-largest shareholder through equity purchase
Kim Chan-hyuk 2024.03.26 16:18
Celltrion annual shareholders' meeting addresses expansion plans, stock price concerns, director remuneration
Lee Han-soo 2024.03.26 13:55
Brokerage predicts US Biosecure Act could benefit Samsung Biologics
Yang Hyeon-su 2024.03.26 13:48
AriBio signs ₩1 trillion deal with Chinese partner for Alzheimer's pill AR1001
Yang Hyeon-su 2024.03.25 15:48
Geo-Young and Samsung Bioepis to collaborate on biosimilar distribution
Yang Hyeon-su 2024.03.22 15:19
SK bioscience paves way for exporting SKY Cellflu to southern hemisphere
Korea Biomedical Review 2024.03.21 13:06
Merck to spend 300 million euros to build bioprocessing plant in Daejeon
Kim Yoon-mi 2024.03.21 10:04
HLB increases stake in HLB Therapeutics to 6.25%
Kim Chan-hyuk 2024.03.20 14:32
Samsung Life Science Fund invests in US ADC firm BrickBio
Lee Han-soo 2024.03.19 11:06
CHA Biotech signs CDMO accord with Cell in Cells to supply organoid treatment
Korea Biomedical Review 2024.03.18 15:02
Celltrion launches Zymfentra in US, setting wholesale cost at $6,181.08 for 2 doses
Lee Han-soo 2024.03.18 11:10
NeoImmuneTech will set up Polish offshoot to conduct European clinical trials
Kim Chan-hyuk 2024.03.15 16:23